| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 8-K | 10-K |
| Revenues: |
| Home Health and Hospice Services | 342.2 | 309.6 | 253.7 | 206.6 | 169.0 | | 142.4 |
| Senior Living Services | 131.0 | 130.1 | 137.3 | 131.9 | 117.0 | | 108.6 |
| Total revenues | 473.2 | 439.7 | 391.0 | 338.5 | 286.1 | 286.1 | 251.0 |
| Revenue growth [+] | 7.6% | 12.5% | 15.5% | 18.3% | 14.0% | | |
| Home Health and Hospice Services | 10.6% | 22.0% | 22.8% | 22.2% | 18.7% | | |
| Senior Living Services | 0.7% | -5.2% | 4.1% | 12.7% | 7.8% | | |
| Cost of goods sold | 448.6 | 427.4 | 367.4 | 329.1 | 262.5 | 243.6 | 31.3 |
| Gross profit | 24.6 | 12.3 | 23.6 | 9.5 | 23.6 | 42.4 | 219.7 |
| Gross margin | 5.2% | 2.8% | 6.0% | 2.8% | 8.2% | 14.8% | 87.5% |
| Selling, general and administrative [+] | 11.9 | 7.6 | 4.7 | 3.8 | 3.0 | 18.8 | 2.5 |
| General and administrative | | | | | | 18.8 | |
| Other operating expenses | -11.9 | -7.6 | -4.7 | -3.8 | -3.0 | | 199.2 |
| EBITDA [+] | 24.6 | 12.3 | 23.6 | 9.5 | 23.6 | 23.6 | 17.9 |
| EBITDA growth | 99.4% | -47.7% | 148.9% | -59.8% | 31.5% | | |
| EBITDA margin | 5.2% | 2.8% | 6.0% | 2.8% | 8.2% | 8.2% | 7.2% |
| Depreciation | 4.9 | 4.8 | 4.7 | 3.8 | 3.0 | 3.0 | 2.4 |
| EBITA | 19.7 | 7.6 | 18.9 | 5.7 | 20.6 | 20.6 | 15.5 |
| EBITA margin | 4.2% | 1.7% | 4.8% | 1.7% | 7.2% | 7.2% | 6.2% |
| Amortization of intangibles | | | | | | | 0.1 |
| EBIT [+] | 19.7 | 7.6 | 18.9 | 5.7 | 20.6 | 20.6 | 15.4 |
| EBIT growth | 160.9% | -60.1% | 233.6% | -72.5% | 34.0% | | |
| EBIT margin | 4.2% | 1.7% | 4.8% | 1.7% | 7.2% | 7.2% | 6.1% |
| Non-recurring items [+] | 7.0 | 2.9 | | | | | |
| Loss (gain) on sale of assets | 7.0 | 2.9 | | | | | |
| Interest expense | 3.8 | 1.9 | 1.2 | 0.4 | | | |
| Interest expense | 3.8 | 1.9 | 1.2 | 0.4 | | | |
| Other income (expense), net | 0.0 | 0.0 | 0.2 | | | | |
| Pre-tax income | 8.9 | 2.7 | 17.9 | 5.3 | 20.6 | 20.6 | 15.4 |
| Income taxes | 1.6 | 0.6 | 2.4 | 2.1 | 4.4 | 4.4 | 5.4 |
| Tax rate | 18.5% | 21.3% | 13.1% | 39.6% | 21.1% | 21.1% | 34.9% |
| Minority interest | 0.6 | -0.5 | -0.2 | 0.6 | 0.6 | | 0.2 |
| Net income | 6.6 | 2.7 | 15.7 | 2.5 | 15.7 | 15.7 | 9.9 |
| Net margin | 1.4% | 0.6% | 4.0% | 0.8% | 5.5% | 5.5% | 3.9% |
| |
| Basic EPS [+] | $0.23 | $0.09 | $0.56 | $0.09 | $0.56 | $0.56 | $0.35 |
| Growth | 140.8% | -83.1% | 514.2% | -83.8% | 59.0% | | |
| Diluted EPS [+] | $0.22 | $0.09 | $0.52 | $0.09 | $0.56 | $0.56 | $0.35 |
| Growth | 150.3% | -83.1% | 505.2% | -84.7% | 59.0% | | |
| |
| Dividends per share [+] | | | | $0.42 | | | |
| Growth | | | -100.0% | | | | |
| |
| Shares outstanding (basic) [+] | 29.1 | 28.4 | 28.0 | 27.8 | 27.8 | 27.8 | 27.8 |
| Growth | 2.3% | 1.3% | 0.7% | 0.0% | 0.0% | | |
| Shares outstanding (diluted) [+] | 30.2 | 30.6 | 30.2 | 29.6 | 27.8 | 27.8 | 27.8 |
| Growth | -1.6% | 1.4% | 2.2% | 6.3% | 0.0% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |